Managing lifestyle diseases at scale
Cardio-metabolic disorders such as diabetes and hypertension are rising rapidly in India, affecting even younger populations. These conditions significantly increase the risk of severe complications if left unmanaged.
Sedentary lifestyle, stress, and dietary changes are driving diabetes, NAFLD, and metabolic syndrome.
Probiotics and microbiome modulation can influence insulin resistance, inflammation, and obesity.
Focus is moving toward early intervention and prevention using microbiome-based therapies.
Dedicated therapies for diabetes and hypertension management
Microbiome-focused metabolic interventions
Preventive healthcare solutions tailored for Indian population
Discover how our innovative solutions can transform patient outcomes